valu usd unless otherwis note
view reiter outperform altria believ
bear thesi larg play catalyst horizon
share trend remain construct name ep
high dividend yield spread vs mo appropri
factor headlin risk may come regulatori chang
estim essenti de-risk
mo grow ep volum declin ye believ
biggest concern investor altria last year
worsen volum outlook think view compani
prospect volum vacuum appropri volum declin
acceler rate offset specif price
realiz strongest clip recent histori see
slow materi near futur marlboro trend continu
improv mo priorit ebit growth volum price
offsetting/slightli exceed volum declin altria get enough
contribut cost save juul flow buyback interest
de-lever continu deliv ep within lt algo
takeaway quarter posit price off-set
underli volum declin chang
underli promot expect price remain strong especi
core marlboro franchis improv perform marlboro
share flat yoy first time quarter marlboro lose share
iqo test market launch septemb provid earli insight
potenti us iqo vari success across asia
europ expect play import role altria portfolio
year come neg industri volum declin worsen
altria also lower outlook year
given continu consum adopt e-cig
state enact minimum age tobacco consumpt altria also
lower volum expect
account varieti factor could impact trend
year notabl launch iqo continu growth e-cig like
feder chang minimum purchas age
estim chang leav estim larg unchang
model volum price
expect juul start contribut
altria model total contribut
year assum juul revenu growth next year
profit margin note ebit equiti invest base
bp impact growth even estim
optimist materi alter ep outlook
price prior trade day market close estimate unless otherwis note
bloomberg capit market estim upside/downside/target
dcf-driven base case altria impli
price-to-earnings assum wacc lt top-lin compound-annual-growth-rate
termin growth rate estim call
cigarett volum declin price
dcf-driven upsid case altria assum
wacc lt top-lin compound-annual-growth-rate termin growth
rate scenario assum cigarett volum
declin low-end rang price
downsid scenario also base dcf
assum revenu compound-annual-growth-rate termin
growth rate primari driver scenario
acceler declin volum fall outsid
assumpt inabl off-set acceler
volum declin price materi slowdown
rate altria share outperform current price mo
share trade price-to-earnings yield
understand make valuat call consum stapl
realli work past year believ
current state overal cpg space make mo attract
place put new money within space compani
essenti hedg three biggest issu face
evolut sell tobacco product ban on-line
rise cost goods/logist make small
percentag cog
rise interest rate fulli acknowledg highlight
risk rate set rise project treasuri
rate rise year-end altria maintain
current yield dividend yield spread versu
would bp year-end
compel level bp benchmark take
account dividend increas altria made
consecut year
competitor product launch success price profil
competitor new product launch import watch
altria result
iqo fda approv roll-out altria manag note
fulli prepar roll iqo market upon
fda approv believ fda approv like howev
expect iqo materi contributor altria top-
line profit howev headlin disappoint around
iqo could spook investor saw upon philip
morri result includ sequenti
deceler iqo drive mo share lower
risk thesi
signific deceler industri volum declin
long-term averag noteworthi innov
e-cigarette/vapor front rise interest rate
deterior tobacco fundament
dcf-driven base case altria impli price-to-earnings assum wacc
lt top-lin compound-annual-growth-rate termin growth rate estim call
cigarett volum declin price price target support
outperform rate
risk rate price target
rise interest rate given tobacco stock often view bond proxi investor
fulli acknowledg highlight risk interest rate expect rise
project treasuri rate rise year-end altria
maintain current yield dividend yield spread versu would
bp year-end compel level bp benchmark take
account dividend increas altria made consecut
deterior tobacco fundament look forward see volum trend normal
back level like closer posit altria suspect abl
realiz consist price past quarter us cigarett industri volum
declin acceler believ follow factor contribut weak
excis tax increas import cigarett consumpt state ca/pa rise ga price
peak condit job lever tobacco consum construct hospit etc
gener lack wage inflat headwind continu would
risk fundament thesi
iqo fda approv roll-out altria manag note fulli prepar roll
iqo market upon fda approv believ fda approv like howev
expect iqo materi contributor altria top-lin profit howev
headlin disappoint around iqo could spook investor saw upon philip
morri result includ sequenti deceler iqo drive
altria group inc engag manufactur sale cigarett smokeless product
wine unit state offer cigarett primarili marlboro brand
smokeless tobacco product copenhagen skoal red seal huski marlboro
snu brand name cigar princip black mild brand pipe tobacco
compani also produc sell blend tabl wine chateau michel
columbia crest name distribut antinori villa maria estat wine champagn
nicola feuillatt unit state addit maintain portfolio leverag
direct financ leas aircraft rail surfac transport electr power real estat
manufactur compani found headquart richmond
ms except ep ratio
sale
net incom common non-gaap
compani report capit market estim
